Decoding the mechanism of Eleutheroside E in treating osteoporosis via network pharmacological analysis and molecular docking of osteoclast-related genes and gut microbiota

Decoding the mechanism of Eleutheroside E in treating osteoporosis via network pharmacological analysis and molecular docking of osteoclast-related genes and gut microbiota

ObjectiveEleutheroside E (EE) is an anti-inflammatory natural compound derived from the edible medicinal herb Acanthopanax senticosus. This study aims to investigate the underlying mechanism of the anti-osteoporosis action of EE through network pharmacology, molecular docking and gut microbiota.Mate...

Full description

Bibliographic Details
Main Authors:	Tianyu Zhou, Yilin Zhou, Dongdong Ge, Youhong Xie, Jiangyan Wang, Lin Tang, Qunwei Dong, Ping Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Endocrinology
Subjects:	Eleutheroside E (EE) postmenopausal osteoporosis (PMO) network pharmacology molecular docking gut microbiota
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1257298/full

Similar Items

Identification of targets and mechanisms for Eleutheroside E in the treatment of cancer
by: Deyong Zeng, et al.
Published: (2022-03-01)

A Metabolomics Study of the Effects of Eleutheroside B on Glucose and Lipid Metabolism in a Zebrafish Diabetes Model
by: Xuelian Dong, et al.
Published: (2024-03-01)

Tea saponin additive to extract eleutheroside B and E from Eleutherococcus senticosus by ultrasonic mediation and its application in a semi-pilot scale
by: Xinyu Yang, et al.
Published: (2022-05-01)

Development and application of a rapid HPLC method for simultaneous determination of hyperoside, isoquercitrin and eleutheroside E in Apocynum venetum L. and Eleutherococcus senticosus
by: Jie Shen, et al.
Published: (2020-05-01)

Evaluation of the Antidepressant Effect of the Functional Beverage Containing Active Peptides, Menthol and Eleutheroside, and Investigation of Its Mechanism of Action in Mice
by: Yuanjin Qi, et al.
Published: (2020-01-01)

Metabolome and transcriptome analysis of eleutheroside B biosynthesis pathway in Eleutherococcus senticosus
by: Hong-Yu Guo, et al.
Published: (2022-06-01)

Eleutheroside B Ameliorates Cardiomyocytes Necroptosis in High-Altitude-Induced Myocardial Injury via Nrf2/HO-1 Signaling Pathway
by: Huxinyue Duan, et al.
Published: (2025-02-01)

Simultaneous quantification method for eleutheroside B, eleutheroside E, chiisanoside, and sesamin using reverse-phase high-performance liquid chromatography coupled with ultraviolet detection and integrated pulsed amperometric detection
by: YeaIn Kim, et al.
Published: (2023-01-01)

Effect of Eleutheroside E on an MPTP-Induced Parkinson’s Disease Cell Model and Its Mechanism
by: Yi Yao, et al.
Published: (2023-04-01)

Prevention of polycystic ovary syndrome and postmenopausal osteoporosis by inhibiting apoptosis with Shenling Baizhu powder compound
by: Jing Liang, et al.
Published: (2022-10-01)

Network pharmacology-based mechanism prediction and pharmacological validation of Bushenhuoxue formula attenuating postmenopausal osteoporosis in ovariectomized mice
by: Chenjie Xia, et al.
Published: (2023-03-01)

Osteoporosis in postmenopausal women is associated with disturbances in gut microbiota and migration of peripheral immune cells
by: Zongjun Ma, et al.
Published: (2024-10-01)

The role of project management office (PMO) manager: A qualitative case study in Indonesia
by: Mohammad Ichsan, et al.
Published: (2023-12-01)

Quality use of medicines: The postmenopausal woman with osteoporosis
by: Andy Gray, et al.
Published: (2003-05-01)

Epigenetics of Osteoporosis
by: Şengül Tural, et al.
Published: (2023-04-01)

Relationships between dietary acid load, genetic factors and cardiometabolic syndrome on risk of osteoporosis among postmenopausal Chinese women
by: Lim, Sook Yee
Published: (2020)

Unveiling the Pharmacological Mechanisms of Eleutheroside E Against Postmenopausal Osteoporosis Through UPLC-Q/TOF-MS-Based Metabolomics
by: Yong-Sheng Ma, et al.
Published: (2020-08-01)

Eleutheroside B alleviates oxidative stress and neuroinflammation by inhibiting the JAK2/STAT3 signaling pathway in a rat high altitude cerebral edema model
by: Yacong He, et al.
Published: (2024-11-01)

Efficacy and safety of pharmacologic therapies for prevention of osteoporotic vertebral fractures in postmenopausal women
by: Fei-Long Wei, et al.
Published: (2023-02-01)

Identification of a potential diagnostic signature for postmenopausal osteoporosis via transcriptome analysis
by: Rui Zeng, et al.
Published: (2022-08-01)

Dendrobium officinale Orchid Extract Prevents Ovariectomy-Induced Osteoporosis in Vivo and Inhibits RANKL-Induced Osteoclast Differentiation in Vitro
by: Qi Wang, et al.
Published: (2018-01-01)

Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis
by: Minsun Kim, et al.
Published: (2020-02-01)

Prevalence of osteoporosis in postmenopausal women at Srinagarind Hospital, Khon Kaen University
by: Surangtip Surangtip, et al.
Published: (2010-03-01)

Corrigendum: Dendrobium officinale Orchid Extract Prevents Ovariectomy-Induced Osteoporosis In Vivo and Inhibits RANKL-Induced Osteoclast Differentiation In Vitro
by: Qi Wang, et al.
Published: (2020-04-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Pharmacognostic Evaluation and HPLC–PDA and HS–SPME/GC–MS Metabolomic Profiling of <i>Eleutherococcus senticosus</i> Fruits
by: Filip Graczyk, et al.
Published: (2021-03-01)

Diversity of the diet is correlated with osteoporosis in post-menopausal women: an Iranian case-control study
by: Behnood Abbasi, et al.
Published: (2024-08-01)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
by: Paula Rackoff
Published: (2009-05-01)

WGCNA Identification of Genes and Pathways Involved in the Pathogenesis of Postmenopausal Osteoporosis
by: Hao ML, et al.
Published: (2021-11-01)

Mechanistic study on the alleviation of postmenopausal osteoporosis by Lactobacillus acidophilus through butyrate-mediated inhibition of osteoclast activity
by: Junjie Dong, et al.
Published: (2024-03-01)

Irisin and Its Role in Postmenopausal Osteoporosis and Sarcopenia
by: Irene Falsetti, et al.
Published: (2024-04-01)

THE PREVALENCE OF PERIODONTAL DISEASE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
by: Ioana Duncea, et al.
Published: (2022-03-01)

Sarcopenia and Balance in Community-dwelling Women with Postmenopausal Osteoporosis
by: Bilinç Doğruöz Karatekin, et al.
Published: (2021-06-01)

SCIMP: A Novel Targeted Gene for Postmenopausal Osteoporosis Progression
by: Xiaolei Sun, et al.
Published: (2023-05-01)

Osteoporosis and cardiovascular diseases
by: S G Anikin, et al.
Published: (2009-08-01)

Potential mechanism of Ziyin Tongluo Formula in the treatment of postmenopausal osteoporosis: based on network pharmacology and ovariectomized rat model
by: Rong-Bin Chen, et al.
Published: (2021-09-01)

Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01)

Evaluation of Serum Osteocalcin Level in Iraqi Postmenopausal Women with Primary Osteoporosis
by: Rana A. Hamdi
Published: (2013-07-01)

Analysis of radiomorphometric indices in postmenopausal patients with osteoporosis: Case report and literature review
by: Ioana Madalina Lescai, et al.
Published: (2021-06-01)

Outcomes of Treatment in Patients with Elderly Postmenopausal Osteoporosis: Comparision of Oral and Parenteral Bisphosphonates
by: Ahmet Aslan, et al.
Published: (2018-08-01)